Group 6 Copy 437
0
    Please wait...

    About This Project

    OncoSynergy, Inc.
    The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and no approved therapies. OncoSynergy is developing a readily manufactured experimental cancer drug, OS2966, which coincidentally targets the receptor hijacked by ebola to infect cells. This project aims to demonstrate that OS2966 inhibits ebola infection of human cells thus providing the impetus for expediting OS2966 for treatment of ebola.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Cat and Human Personality Interaction Project

    Millions of cats that enter US animal shelters every year are euthanized. Currently, there is little scientific...

    How is the environment affecting fungal pathogen abundance and incidence in leatherback sea turtle nests?

    We will correlate environmental conditions and how they affect fungal pathogen abundance in leatherback...

    Are cryptic characteristics preventing the protection of two similar Sphingidae moths?

    This project is aimed at understanding the morphological differences between two species of Sphingidae...

    Backer Badge Funded

    A biology project funded by 47 people